{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:20:19Z","timestamp":1787804419978,"version":"build-2784847793"},"reference-count":32,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003979","name":"Istituto Oncologico Romagnolo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003979","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/04mrg3p52","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/00789fa95","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Vacuum-assisted breast biopsy (VABB) is widely used for the diagnosis of nonpalpable breast cancer but is not considered definitive treatment because microscopic residual disease may persist within or around the biopsy cavity. The ARTHE phase I trial evaluated a cavity-targeted radionuclide strategy based on same-session sequential intralesional administration of avidin followed by [90Y]Y-DOTA-biotin after VABB. Methods: Eighteen women with nonpalpable breast cancer measuring \u226415 mm and a skin-to-cavity distance \u2265 13 mm were treated in three sequential activity-escalation cohorts. The primary objective was to assess acute local and systemic safety, including dose-limiting toxicity. The protocol-specified co-primary objective was to evaluate preliminary antitumor activity, assessed as breast-only pathologic complete response (pCR) at surgery. Given the phase I single-arm design, pCR was analyzed descriptively. The protocol-specified secondary objective was patient-specific dosimetry. Additional exploratory assessments included post-injection biodistribution and integration with subsequent breast-conserving surgery. Results: No dose-limiting toxicities, grade \u2265 3 adverse events, clinically relevant hematologic toxicity, treatment discontinuations, hospitalizations, or treatment-related surgical delays were observed. Local toxicity was limited to grade 1 injection-site pain and\/or erythema. Post-injection imaging consistently demonstrated focal intralesional localization without clinically relevant extra-lesional uptake. All patients underwent breast-conserving surgery 4\u20137 weeks after treatment. No residual tumor cellularity (RTC), from either invasive or in situ carcinoma, was identified in the breast surgical specimen in 5\/18 patients (27.8%). However, because diagnostic VABB may have removed part or all of the malignant lesion, the absence of residual carcinoma at surgery cannot be attributed specifically to the radionuclide treatment. Conclusions: The intralesional avidin-mediated local trapping strategy using [90Y]Y-DOTA-biotin after VABB was feasible, showed favorable acute and short-term tolerability, was associated with early focal localization on post-injection imaging, and was compatible with standard breast-conserving surgery. Controlled studies are warranted to determine the therapeutic contribution of this post-biopsy cavity-targeted strategy, optimize administered activity, and refine patient selection.<\/jats:p>","DOI":"10.3390\/cancers18172760","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:01:07Z","timestamp":1787670067000},"page":"2760","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-VABB Cavity-Targeted Avidin-Pretargeted [90Y]Y-DOTA-Biotin in Nonpalpable Breast Cancer: A Phase I Activity-Escalation Study (ARTHE)"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7699-262X","authenticated-orcid":false,"given":"Maddalena","family":"Sansovini","sequence":"first","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sanna","sequence":"additional","affiliation":[{"name":"Azienda Unit\u00e0 Sanitaria Locale della Romagna, 47122 Forl\u00ec, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8415-1137","authenticated-orcid":false,"given":"Paola","family":"Possanzini","sequence":"additional","affiliation":[{"name":"Azienda Unit\u00e0 Sanitaria Locale della Romagna, 47122 Forl\u00ec, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7230-9267","authenticated-orcid":false,"given":"Emanuela","family":"Scarpi","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Marini","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3960-7737","authenticated-orcid":false,"given":"Silvia","family":"Nicolini","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9566-7670","authenticated-orcid":false,"given":"Ilaria","family":"Grassi","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Caroli","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Amadori","sequence":"additional","affiliation":[{"name":"Azienda Unit\u00e0 Sanitaria Locale della Romagna, 47122 Forl\u00ec, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Curcio","sequence":"additional","affiliation":[{"name":"Azienda Unit\u00e0 Sanitaria Locale della Romagna, 47122 Forl\u00ec, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Simoncini","sequence":"additional","affiliation":[{"name":"Azienda Unit\u00e0 Sanitaria Locale della Romagna, 47122 Forl\u00ec, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Fabbri","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Nanni","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3587-1768","authenticated-orcid":false,"given":"Manuela","family":"Monti","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7734-3426","authenticated-orcid":false,"given":"Lilla","family":"Vizza","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1087-9146","authenticated-orcid":false,"given":"Anna","family":"Miserocchi","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5380-6185","authenticated-orcid":false,"given":"Valentina","family":"Di Iorio","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cuni","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1983-3291","authenticated-orcid":false,"given":"Maria Luisa","family":"Belli","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1146-6570","authenticated-orcid":false,"given":"Matteo","family":"Costantini","sequence":"additional","affiliation":[{"name":"Azienda Unit\u00e0 Sanitaria Locale della Romagna, 47122 Forl\u00ec, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Falcini","sequence":"additional","affiliation":[{"name":"Azienda Unit\u00e0 Sanitaria Locale della Romagna, 47122 Forl\u00ec, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Paganelli","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"},{"name":"Department of Translational Medicine and for Romagna, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7455-6253","authenticated-orcid":false,"given":"Federica","family":"Matteucci","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-3845","authenticated-orcid":false,"given":"Anna","family":"Sarnelli","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47121 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.breast.2009.01.001","article-title":"Ultrasound-guided vacuum-assisted breast biopsy in the assessment of C3 breast lesions by ultrasound-guided fine-needle aspiration cytology: Results and costs in comparison with surgery","volume":"18","author":"Abbate","year":"2009","journal-title":"Breast"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.32074\/1591-951X-1113","article-title":"Consensus document on preoperative diagnostic procedures in breast lesions","volume":"117","author":"Marletta","year":"2025","journal-title":"Pathologica"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0221-0363(05)81484-2","article-title":"Ultrasound-guided vacuum-assisted biopsy: Review of 382 cases","volume":"86","author":"Plantade","year":"2005","journal-title":"J. Radiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00428-023-03566-x","article-title":"Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)","volume":"483","author":"Elfgen","year":"2023","journal-title":"Virchows Arch."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2214\/AJR.10.4208","article-title":"Stereotactic vacuum-assisted breast biopsy is not a therapeutic procedure even when all mammographically found calcifications are removed: Analysis of 4086 procedures","volume":"195","author":"Penco","year":"2010","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"111049","DOI":"10.1016\/j.ejrad.2023.111049","article-title":"Vacuum-assisted excision of small breast cancers under ultrasound guidance","volume":"167","author":"Niinikoski","year":"2023","journal-title":"Eur. J. Radiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Valadares, C.N., Couto, H.L., Soares, A.N., Toppa, P.H., Ricardo, B.P., McIntosh, S.A., Sharma, N., and Resende, V. (2023). Potential role of vacuum-assisted procedures in resecting breast cancers and highlighting selection criteria to support future trials. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1239574"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/bjr\/tqae028","article-title":"Minimally invasive treatment of early, good prognosis breast cancer\u2014Is this feasible?","volume":"97","author":"Mactier","year":"2024","journal-title":"Br. J. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41523-025-00744-9","article-title":"Mapping the current landscape of locoregional therapy de-escalation trials in early breast cancer: A systematic review","volume":"11","author":"McCrorie","year":"2025","journal-title":"npj Breast Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21037\/tbcr-24-43","article-title":"Preoperative partial breast radiation for favorable early-stage breast cancer: A narrative review","volume":"6","author":"McDuff","year":"2025","journal-title":"Transl. Breast Cancer Res."},{"key":"ref_11","first-page":"55","article-title":"Detection of prosthetic vascular graft infection using avidin\/indium-111-biotin scintigraphy","volume":"37","author":"Samuel","year":"1996","journal-title":"J. Nucl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.breast.2006.10.003","article-title":"IART\u00ae: Intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation","volume":"16","author":"Paganelli","year":"2007","journal-title":"Breast"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5646s","DOI":"10.1158\/1078-0432.CCR-07-1058","article-title":"Intraoperative avidination for radionuclide therapy: A prospective new development to accelerate radiotherapy in breast cancer","volume":"13","author":"Paganelli","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_14","first-page":"166","article-title":"IART\u00ae (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients: Technical aspects and preliminary results of a phase II study with 90Y-labelled biotin","volume":"4","author":"Paganelli","year":"2010","journal-title":"Ecancermedicalscience"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0076-6879(71)18342-5","article-title":"Spectrophotometric determination of avidin and biotin","volume":"18A","author":"Green","year":"1970","journal-title":"Methods Enzymol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1007\/s00259-010-1536-8","article-title":"EANM procedure guidelines for therapy of benign thyroid disease","volume":"37","author":"Stokkel","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s00259-012-2197-6","article-title":"3D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART) combined with external beam radiation therapy","volume":"39","author":"Ferrari","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bjc.6600047","article-title":"Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: A pilot study","volume":"86","author":"Grana","year":"2002","journal-title":"Br. J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s002590050397","article-title":"Antibody-guided three-step therapy for high-grade glioma with yttrium-90 biotin","volume":"26","author":"Paganelli","year":"1999","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_20","first-page":"131","article-title":"Clinical optimization of pretargeted radioimmunotherapy with antibody\u2013streptavidin conjugate and 90Y-DOTA-biotin","volume":"41","author":"Breitz","year":"2000","journal-title":"J. Nucl. Med."},{"key":"ref_21","first-page":"227","article-title":"Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: Phase I study and preliminary therapeutic results","volume":"16","author":"Paganelli","year":"2001","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1040-8428(01)00133-0","article-title":"Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin\u2019s lymphoma (NHL)","volume":"40","author":"Weiden","year":"2001","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_23","first-page":"406","article-title":"Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody\/streptavidin in patients with metastatic colon cancer","volume":"6","author":"Knox","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0167-5699(84)90027-6","article-title":"The avidin-biotin complex in immunology","volume":"5","author":"Wilchek","year":"1984","journal-title":"Immunol. Today"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnci\/90.1.25","article-title":"Avidin targeting of intraperitoneal tumor xenografts","volume":"90","author":"Yao","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s002590050366","article-title":"Three-step radioimmunotherapy with yttrium-90 biotin: Dosimetry and pharmacokinetics in cancer patients","volume":"26","author":"Cremonesi","year":"1999","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_27","first-page":"105","article-title":"Dosimetric model for locoregional treatments of brain tumors with ^90Y-conjugates: Clinical application with 90Y-DOTATOC","volume":"47","author":"Ferrari","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1088\/0031-9155\/51\/20\/020","article-title":"A theoretical investigation into post-operative, intracavitary beta therapy of high-grade glioblastomas using yttrium-90","volume":"51","author":"Stefanou","year":"2006","journal-title":"Phys. Med. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41598-021-03807-6","article-title":"Modelling a new approach for radio-ablation after resection of breast ductal carcinoma in-situ based on the BAT-90 medical device","volume":"12","author":"Sarnelli","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Raza, S., Lymberis, S.C., Ciervide, R., Axelrod, D., Fenton-Kerimian, M., Magnolfi, C., Rosenstein, B., DeWyngaert, J.K., and Formenti, S.C. (2012). Comparison of acute and late toxicity of two regimens of 3- and 5-week concomitant boost prone IMRT to standard 6-week breast radiotherapy. Front. Oncol., 2.","DOI":"10.3389\/fonc.2012.00044"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clon.2021.04.016","article-title":"Five-fraction radiotherapy for breast cancer: FAST-Forward to implementation","volume":"33","author":"Brunt","year":"2021","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.23736\/S1824-4785.16.02744-8","article-title":"Therapeutic schemes in ^177Lu and ^90Y-PRRT: Radiobiological considerations","volume":"61","author":"Sarnelli","year":"2017","journal-title":"Q. J. Nucl. Med. Mol. Imaging"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2760\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:15:34Z","timestamp":1787804134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":32,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18172760"],"URL":"https:\/\/doi.org\/10.3390\/cancers18172760","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}